Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies
Lists
Only you see this
Abstract
Our study provides a reliable strategy for the large-scale generation of fratricide-resistant CD7 CAR-iNK cells with robust anti-tumor effects from hPSCs, offering a promising cell product to treat T-cell malignancies.
BibTeX
@article{lin2025engineered,
author = {Yunqing Lin and Ziyun Xiao and Fangxiao Hu and Xiujuan Zheng and Chenyuan Zhang and Yao Wang and Yanhong Liu and Dehao Huang and Zhiqian Wang and Chengxiang Xia and Qitong Weng and Leqiang Zhang and Yaoqin Zhao and Hanmeng Qi and Yiyuan Shen and Yi Chen and Fan Zhang and Jiaxin Wu and Pengcheng Liu and Jiacheng Xu and Lijuan Liu and Yanping Zhu and Jingliao Zhang and Wenbin Qian and Aibin Liang and Xiaofan Zhu and Tongjie Wang and Mengyun Zhang and Jinyong Wang},
title = {{Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies}},
journal = {Journal of Hematology \& Oncology},
year = {2025},
doi = {10.1186/s13045-025-01712-3},
}Loading related content...